...refractory. Relapse is when cancer returns after successful treatment. When multiple myeloma becomes refractory, it means it’s not responding to treatment. Your healthcare team will work with you to develop...
...treatments for multiple myeloma What's the most successful treatment for multiple myeloma? Can you fully recover from multiple myeloma? What is the longest you can live with multiple myeloma? What...
...cancer * Diabetes mellitus * Malnutrition * Hepatitis * Cirrhosis **Treatment:** Treatment aims to manage pain and complications: * Pain medication * Insulin therapy for diabetes management * Nutritional support...
...Nadel’s Textbook of Respiratory Medicine, 5th edition, Saunders, 2010. Johnson DH, Blot WJ, Carbone DP, et al. Cancer of the lung: non–small cell lung cancer and small cell lung cancer....
...change or add to an ongoing treatment A major, life-threatening surgery was suggested as treatment The child is diagnosed with a serious condition They want to explore different treatment options...
...risk of disease:** Treatment can help to reduce the risk of disease by improving overall health and well-being. ### What to Expect During a Treatment Session: _A typical Treatment session...
...diagnosis.[27] Graves’ disease treatment Treatment for Graves’ disease is generally the same as treatment for hyperthyroidism. It typically requires lifelong monitoring and management of thyroid hormone levels, with the help...
...more recent developments in cancer treatment. It is non-surgical and minimally invasive. Its goal is to destroy tumours completely. If this is not possible, the volume or number of tumour...
...purpose of the follow-up is to (1) monitor the risks and complications associated with the treatment, (2) determine the effectiveness of such treatment, (3) manage the complications or prevent them...
...if their mothers, sisters, and other close female relatives have had ovarian cancer. Breast cancer. The hormones produced by the ovaries can increase breast cancer risk in some women. Removing...
